Here, we measured the serum Hsp90α level in lung cancer patients and investigated the diagnostic value of Hsp90α combined with other traditional lung cancer biomarkers (CEA, CYFRA21-1, and NSE) and its role in monitoring the treatment response of lung cancer patients. This evidence concerns the gene ENO2 and lung carcinoma.